A catalytically active and recyclable bioelastomer inspired by metalloenzymes
Source abstract
Abstract
Catalysis is a fundamental principle of biological systems, yet synthetic biomaterials seldom incorporate catalytic activity as a core design principle. Here, we introduce a polymeric network constructed by crosslinking imidazole-functionalized polymers using Cu 2+ ions, yielding an elastomer with enzyme-mimetic reactivity. This bioinspired design enables sustained nitric oxide (NO) generation in serum and broad-spectrum antioxidant activity against superoxide, hydrogen peroxide, and hydroxyl radicals, mimicking the functions of superoxide dismutase, catalase, and peroxidases. Catalytic activity depends on Cu 2+ coordination, confirming a defined structure-function mechanism. The elastomer demonstrates minimal hemolysis, reduced platelet adhesion, and high biocompatibility upon subcutaneous implantation. Remarkably, the material can be fully recycled by a simple immersion in acetic acid that reverses Cu 2+ coordination without compromising the integrity of the polymer. This closed-loop feature aligns with circular economy principles and greatly extends the functional lifespan of the material. By integrating mechanical robustness, catalytic activity, and recyclability, this material bridges a critical gap between natural and engineered systems, establishing a new framework for catalytically active and sustainable biomaterials. • Minute amount of copper ions form crosslinks in a tough elastomer. • The materials have inherent catalytic activities. • Bioactivity 1: sustained N itric O xide generation. • Bioactivity 2: broad-spectrum R eactive O xygen S pecies scavenging. • The bioactive material is fully recyclable without loss of function.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Advanced Nanomaterials in Catalysis · Polymer Surface Interaction Studies · Nanoplatforms for cancer theranostics
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (83)
Show source-provided references
1. Drug-eluting stents in vascular intervention10.1016/S0140-6736(03)12275-1 ↗
2. Surface modification of polymers by plasma treatments for the enhancement of biocompatibility and controlled drug release10.1016/j.surfcoat.2013.02.042 ↗
3. Stimulus-Responsive targeted nanomicelles for effective cancer therapy10.2217/nnm.09.44 ↗
4. The use of intraocular corticosteroids10.1517/14656560903160671 ↗
5. Designs, applications, and future perspectives of nanozymes in orthopedics and dentistry10.22203/eCM.v052a06 ↗
6. The multiple roles of urocanic acid in health and disease10.1016/j.jid.2020.07.017 ↗
7. Microbial production of 1,3-propanediol10.1007/s002530051523 ↗
8. Optimization study for metabolomics analysis of human sweat by liquid chromatography–tandem mass spectrometry in high resolution mode10.1016/j.chroma.2014.01.071 ↗
9. A critical assessment of the evidence from XAFS and crystallography for the breakage of the imidazolate bridge during catalysis in CuZn superoxide dismutase10.1016/S0969-2126(97)00194-9 ↗
10. Combined EXAFS and DFT structure calculations provide structural insights into the 1:1 multi-histidine complexes of CuII, CuI, and ZnII with the tandem octarepeats of the Mammalian prion protein10.1002/chem.201304201 ↗
11. X-ray absorption spectroscopy of metal-histidine coordination in metalloproteins. Exact simulation of the EXAFS of tetrabis(imidazole)copper(II) nitrate and other copper-imidazole complexes by the use of a multiple-scattering treatment10.1021/ja00257a042 ↗
12. A key structural role for active site type 3 copper ions in human ceruloplasmin10.1074/jbc.M207188200 ↗
13. Mitochondrial copper metabolism and delivery to cytochrome c oxidase10.1002/iub.50 ↗
14. Determination and analysis of the 2 Å structure of copper, zinc superoxide dismutase10.1016/0022-2836(82)90174-7 ↗
15. Cellular mechanisms and physiological consequences of redox-dependent signalling10.1038/nrm3801 ↗
16. H2O2 and endothelium-dependent cerebral arteriolar dilation. Implications for the identity of endothelium-derived relaxing factor generated by acetylcholine10.1161/01.HYP.16.2.162 ↗
17. Regulation of VEGF-induced endothelial cell migration by mitochondrial reactive oxygen species10.1152/ajpcell.00322.2010 ↗
18. Reactive oxygen species enhance differentiation of human embryonic stem cells into mesendodermal lineage10.3858/emm.2010.42.3.018 ↗
19. Hydrogen peroxide as a mediator of programmed cell death in the blastocyst10.1111/j.1432-0436.1991.tb00880.x ↗
20. Evidence of oxidative stress in chronic venous ulcers10.1046/j.1524-475X.2003.11304.x ↗
21. Biological production, detection, and fate of hydrogen peroxide10.1089/ars.2017.7425 ↗
22. The molecular mechanism of the catalase reaction10.1021/ja9018572 ↗
23. Interaction of bovine erythrocyte superoxide dismutase with hydrogen peroxide. Inactivation of the enzyme10.1021/bi00695a010 ↗
24. Ultrasmall copper-based nanoparticles for reactive oxygen species scavenging and alleviation of inflammation related diseases10.1038/s41467-020-16544-7 ↗
25. O−2 Decay catalyzed by Cu2+ and Cu+ ions in aqueous solutions: a pulse radiolysis Study for atmospheric chemistry10.1002/bbpc.19930970604 ↗
26. Investigation of the generation of hydroxyl radicals and their oxidative role in the presence of heterogeneous copper catalysts10.1016/j.chemosphere.2007.05.041 ↗
27. Enhanced cancer therapy by hypoxia-responsive copper metal-organic frameworks nanosystem10.1016/j.biomaterials.2020.120278 ↗
28. Targeted alleviation of ischemic stroke reperfusion via atorvastatin-ferritin Gd-layered double hydroxide
29. Production of superoxide radicals and hydrogen peroxide by NADH-ubiquinone reductase and ubiquinol-cytochrome c reductase from beef-heart mitochondria10.1016/0003-9861(77)90035-2 ↗
30. An NADPH oxidase superoxide-generating system in the rabbit aorta10.1152/ajpheart.1995.268.6.H2274 ↗
31. Quantitative aspects of the production of superoxide anion radical by milk Xanthine oxidase10.1016/S0021-9258(18)62884-4 ↗
32. Mitochondria and reactive oxygen species10.1016/j.freeradbiomed.2009.05.004 ↗
33. Investigations of riboflavin photolysis via coloured light in the nitro blue tetrazolium assay for superoxide dismutase activity10.1016/j.jphotobiol.2015.04.028 ↗
34. Roles and current applications of S-nitrosoglutathione in anti-infective biomaterials
35. The blood compatibility challenge. Part 2: protein adsorption phenomena governing blood reactivity10.1016/j.actbio.2019.06.022 ↗
36. PdAu alloy nanoparticle catalysts: effective candidates for nitrite reduction in water10.1021/acscatal.6b03647 ↗
37. Bio-inspired hemocompatible surface modifications for biomedical applications10.1016/j.pmatsci.2022.100997 ↗
38. Estimation of nitric oxide production and reactionrates in tissue by use of a mathematical model10.1152/ajpheart.1998.274.6.H2163 ↗
39. Water-Stable metal-organic Framework/Polymer composites compatible with human hepatocytes10.1021/acsami.6b05948 ↗
40. Surface-Catalyzed nitric oxide release via a metal organic framework enhances antibacterial surface effects10.1021/acsami.1c17248 ↗
41. Progress and promise of nitric oxide-releasing platforms
42. Metal-Organic Framework/Chitosan hybrid materials promote nitric oxide release from S-Nitrosoglutathione in aqueous solution10.1021/acsami.6b14937 ↗
43. Polyurethane with tethered copper(II)–cyclen complex: preparation, characterization and catalytic generation of nitric oxide from S-nitrosothiols10.1016/j.biomaterials.2008.02.004 ↗
44. Multifunctional S-Nitroso-N-acetylpenicillamine-Incorporated medical-grade polymer with selenium interface for biomedical applications10.1021/acsami.9b10610 ↗
45. Tunable nitric oxide release from S-Nitroso-N-acetylpenicillamine via catalytic copper nanoparticles for biomedical applications10.1021/acsami.7b01408 ↗
46. Cu(II)-Organic coordination polymer networks for persistent nitric oxide release in tumor therapy10.1021/acs.biomac.4c01071 ↗
47. Complement inhibition in biomaterial- and biosurface-induced thromboinflammation10.1016/j.smim.2016.04.006 ↗
48. Nitric oxide and its antithrombotic action in the cardiovascular system10.2174/1568006053005047 ↗
49. Effects of extracellular matrix viscoelasticity on cellular behaviour10.1038/s41586-020-2612-2 ↗
50. A tough biodegradable elastomer10.1038/nbt0602-602 ↗
51. Recombinant human elastin polypeptides self-assemble into biomaterials with elastin-like properties10.1002/bip.10512 ↗
52. Elastic proteins: biological roles and mechanical properties10.1098/rstb.2001.1022 ↗
53. Chelation crosslinking of biodegradable elastomers10.1002/adma.202003761 ↗
54. Mechanical characterisation of polyurethane elastomer for biomedical applications10.1016/j.jmbbm.2009.03.005 ↗
55. Properties of polyurethane thin films
56. Polyurethane elastomers with low modulus and hardness based on novel copolyether macrodiols10.1002/(SICI)1097-4628(19970307)63:10<1373::AID-APP18>3.0.CO;2-5 ↗
57. On the large strain deformation behavior of silicone-based elastomers for biomedical applications10.1016/j.polymertesting.2016.12.029 ↗
58. Dynamic covalent polymer networks with mechanical and mechanoresponsive properties reinforced by strong hydrogen bonding10.1039/D2PY00179A ↗
59. The influence of hydrogen bonding side-groups on viscoelastic behavior of Linear and network polymers10.1021/ma402368s ↗
60. Impact of matrix stiffness on fibroblast function10.1016/j.msec.2017.02.001 ↗
61. Study of stiffness effects of poly(amidoamine)–poly(n-isopropyl acrylamide) hydrogel on wound healing10.1016/j.colsurfb.2015.08.041 ↗
62. Mechanism of regulation of stem cell differentiation by matrix stiffness10.1186/s13287-015-0083-4 ↗
63. Mechanics of breathing
64. Function–structure relationship of elastic arteries in evolution: from microfibrils to elastin and elastic fibres10.1016/S0369-8114(01)00147-X ↗
65. 2002
66. Copper as an essential nutrient10.1093/ajcn/63.5.791 ↗
67. Copper promotion of angiogenesis in isolated rat aortic ring: role of vascular endothelial growth factor10.1016/j.jnutbio.2013.08.013 ↗
68. Biocompatibility analysis of PLA based candidate materials for cardiovascular stents in a rat subcutaneous implant model10.1016/j.acthis.2020.151615 ↗
69. Subcutaneous tissue response to titanium, poly(ϵ-caprolactone), and carbonate-substituted hydroxyapatite-coated poly(ϵ-caprolactone) plates: a rabbit study10.1002/jbm.a.34542 ↗
70. Lack of CXC chemokine receptor 3 signaling leads to hypertrophic and hypercellular scarring10.2353/ajpath.2010.090564 ↗
71. Delayed and deficient dermal maturation in mice lacking the CXCR3 ELR-Negative CXC chemokine receptor10.2353/ajpath.2007.061092 ↗
72. Phagocytic leukocytes and reactive oxygen species10.1007/s00418-009-0565-5 ↗
73. Reactive oxygen species scavenging potential contributes to hypertrophic scar Formation10.1016/j.jss.2019.06.006 ↗
74. The role of oxidative stress and antioxidants in diabetic wound healing10.1155/2021/8852759 ↗
75. Thermal 1,3-Trityl migrations in diels−alder domino reactions of 1-Trityl-4-vinyl-1H-imidazoles10.1021/jo100416c ↗
76. Room temperature polyesterification10.1021/ma00203a013 ↗
77. Nitric oxide measurement by chemiluminescence detection10.1016/1058-6741(92)90045-Y ↗
78. Nitric oxide generation from endogenous substrates using metal–organic frameworks: inclusion within Poly(vinyl alcohol) membranes to investigate reactivity and therapeutic potential10.1021/acsami.7b11846 ↗
79. Ceria nanoparticles as an unexpected catalyst to generate nitric oxide from S-Nitrosoglutathione10.1002/smll.202105762 ↗
80. Nitric oxide and S-nitrosothiols in human blood10.1016/S0009-8981(03)00046-9 ↗
81. Dual action nitric oxide and fluoride ion-releasing hydrogels for combating dental caries10.1021/acsami.2c02301 ↗
82. Requirement of the chemokine receptor CXCR3 for acute allograft rejection10.1084/jem.192.10.1515 ↗
83. Matricellular protein Tenascin-C enhances mesenchymal stem cell angiogenic and wound healing efficacy under ischemic conditions10.1002/term.3367 ↗